Navigation Links
Hadasit Bio-Holdings CEO Letter to Shareholders
Date:4/9/2013

JERUSALEM, April 9, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that it has released the following letter to its shareholders:

Dear Shareholders and Investors,

2012 proved to be a year of maturation and growth for Hadasit Bio-Holdings (HBL). Over the past twelve months our portfolio companies have advanced significantly both scientifically and operationally.  We've taken this momentum into the current year and already we are starting to reap the benefits of our diligence, patience and execution.  As a recent example, one of our flagship portfolio companies, Enlivex Therapeutics, just received orphan drug status for its ApoCell treatment.  The orphan drug status grants Enlivex seven years of exclusivity for treatment based on immune tolerance for GVHD.  This is just one example of the successful milestones our portfolio companies have been able to achieve and will continue to achieve over the coming months and years.

Not only will all of our portfolio companies continue to push forward and advance their science following the successes we had in the past year, but we will also advance ourselves from the holding company level.  For instance, in the midst of a very tough market our shareholders continued to display confidence in our growth potential after we saw over 99% participation in a rights offering we held earlier in 2012 that raised capital of over 5M NIS to be reinvested into the portfolio. 

The past year was highlighted by our portfolio companies attracting new strategic partners, earning successful results in various clinical trials, receiving sizable grants from various sources—including the Israeli government—an
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
5. NeoStems CEO Letter to Shareholders
6. Genesis Biopharma Issues Letter To Shareholders
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Ronald L. Chez Files Amended 13D and Letter to the Board
10. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
11. Amarantus BioSciences Issues CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014 Nerium International, the ... in the spotlight again. Nerium will showcase its ... NeriumFirmTM Body Contouring Cream to Hollywood’s elite at ... during the 66th Primetime Emmy® Awards. , Developed ... third-party clinical trials show that NeriumAD night cream ...
(Date:8/21/2014)... the Institute for Molecular Medicine Finland (FIMM), University ... a novel "man and machine" decision support system ... was described in PLOS One scientific ... on computer vision algorithms similar to those used ... only the diagnostically most relevant areas. Tablet computers ...
(Date:8/21/2014)... 2014 Telomere Biosciences, LLC (Telomere Biosciences) ... for Dogs" with Telomerase Activation Complex , ... world for dogs. Telomeres are the protective caps ... body. A wealth of ground-breaking research by some ... and Aging, including Nobel laureates, has demonstrated a ...
(Date:8/21/2014)... -- China Cord Blood Corporation (NYSE: CO ) ... results for the first quarter of fiscal year 2015 ... the US.  The Company will host ... August 29, 2014 to discuss its financial performance and ... followed by a question and answer session.  Interested parties ...
Breaking Biology Technology:Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2
... BioSpace and BioMed Central are announcing the ... Network today, a new online community ... job opportunities and industry news. ... http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO ) (Logo: ...
... FRANCISCO, Calif.,  Sept. 15 Veracyte, Inc., a ... molecular cytology, announced that initial data from its ... at the 14th International Thyroid Congress, held in ... molecular test classified inconclusive thyroid nodule fine needle ...
... Sept. 14 /PRNewswire-FirstCall/ - Dynamic Ventures Corp. (OTC:BB: DYNV), ... term agreement with One Tree Development Inc. for rights ... commercial and residential construction nationally and internationally. One Tree ... One Tree is a corporation formed for ...
Cached Biology Technology:BioSpace and BioMed Central Create Global Career Community 2New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples 2New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples 3Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build. 2Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build. 3
(Date:8/22/2014)... to Research Careers) Program has announced the travel award ... Exercises Workshop which will be held on the FASEB ... These awards are meant to help support the ... in the the FASEB Grant Writing Seminar & Practical ... totaling $20,350. , The FASEB MARC Program is funded ...
(Date:8/22/2014)... are strong antioxidants and can reduce free ... neurons against oxidative stress? Jianbo Zhao and ... Liaoning Medical University, China discovered that green ... inhibit neuronal apoptosis, indicating green tea polyphenols ... neurons under oxidative stress. The relevant study ...
(Date:8/21/2014)... toxins in past decade, GTA still violates Canada,s ... while the Greater Toronto Area (GTA) has significantly ... smog, the city continues to violate the Canada-wide ... cause or aggravate health problems such as asthma, ... set of complex photochemical reactions involving volatile organic ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2
... percent of the major global cereal crops rice, ... possible yields in farmers, fields, according to University of ... . These findings raise concerns about efforts to increase ... these crops have recently decreased or plateaued. Future projections ...
... shrub that grows on just a single island in the ... and genus. It is also one of the oldest flowering ... ago. Now, researchers from Indiana University, with the U.S. Department ... and the Institute of Research for Development in New Caledonia, ...
... constant reconfiguration of the connections between nerve cells. Two ... mechanisms that underlie the learning process. Learning and ... nerve connections in the brain. Both processes are based ... cells the so-called synapses which alter their ...
Cached Biology News:UNL research raises concerns about global crop projections 2A gluttonous plant reveals how its cellular power plant devours foreign DNA 2A gluttonous plant reveals how its cellular power plant devours foreign DNA 3Neurobiology: The logistics of learning 2Neurobiology: The logistics of learning 3
... The QPatch sports 16-independent channels for ... is used for screening against voltage-gated ion ... such as GABA channels. The four ... faster throughput for ion channel drug discovery. ...
... systems need to be able to handle larger ... ports, as well as interface with telemetry systems. ... more, particularly with dogs, pigs, and primates. ... starting time, and the computer can be located ...
... Plate is a 96-well ELISA-compatible plate ... antibody (mouse IgG 1 ) is ... glutathione-S-transferase (GST), and binds with high ... protein in which the tag is ...
... projects are focused on sequencing, analysis of ... other areas of genomics and proteomics, EvoQuest ... meet your research and manufacturing challenges. Invitrogen ... your project from beginning to end in ...
Biology Products: